Organogenesis Holdings
ORGO
121 hedge funds and large institutions have $147M invested in Organogenesis Holdings in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 48 reducing their positions, and 39 closing their positions.
124% more call options, than puts
Call options by funds: $94K | Put options by funds: $42K
6.74% less ownership
Funds ownership: 54.76% → 48.02% (-6.7%)
18% less funds holding
Funds holding: 147 → 121 (-26)
27% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 48
59% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 39
59% less capital invested
Capital invested by funds: $360M → $147M (-$213M)
Top Buyers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.91M |
| 2 |
Los Angeles Capital Management
Los Angeles,
California
|
+$1.26M |
| 3 |
D.E. Shaw & Co
New York
|
+$1.07M |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$959K |
| 5 |
Renaissance Technologies
New York
|
+$865K |
Top Sellers
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$12.4M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.51M |
| 3 |
Jane Street
New York
|
-$2.61M |
| 4 |
Millennium Management
New York
|
-$2.51M |
| 5 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$1.65M |
ORGO Hedge Fund Activity: Q1 2026 in Review
121 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q1 2026, worth a combined $147M — down 59% from $360M a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of ORGO and 16 opened new positions — a net loss of 23 holders — while 48 trimmed existing stakes and 35 added.
The largest buyer was Sphera Funds Management, opening a new position worth an estimated $1.91M. The largest seller was Assenagon Asset Management, cutting an estimated $12.4M.
- 121 institutional investors held Organogenesis Holdings (ORGO) as of Q1 2026, down from 147 in Q4 2025.
- Funds reported $147M of Organogenesis Holdings stock for Q1 2026, down 59% quarter-over-quarter.
- 16 funds opened new Organogenesis Holdings positions in Q1 2026 and 39 closed out, a net change of -23 holders.
- The largest Organogenesis Holdings buyer in Q1 2026 was Sphera Funds Management, an estimated $1.91M added.
- The largest Organogenesis Holdings seller in Q1 2026 was Assenagon Asset Management, an estimated $12.4M sold.
Based on aggregated 13F filings for Q1 2026.